JOHN J MCCABE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN J MCCABE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN J MCCABE. JOHN J MCCABE is a Chief Accounting Officer in INTERLEUKIN GENETICS INC ($ILIU) and a Chief Financial Officer in Eleven Biotherapeutics, Inc. ($EBIO) and a Senior Vice President, Finance in Eleven Biotherapeutics, Inc. ($EBIO) and a Vice President, Finance in resTORbio, Inc. ($TORC).
Address: 135 BEAVER STREET WALTHAM 02452 MA
Companies in which JOHN J MCCABE is an Insider
Adicet Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN J MCCABE: Vice President, Finance
Holdings: 12,867 shares
Latest Transaction: Dec 06 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERLEUKIN GENETICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of JOHN J MCCABE: Chief Accounting Officer
Holdings: 8,000 shares
Current Value: $800
Latest Transaction: Feb 08 2006
$ILIU Market Capitalization: $22.11M
$ILIU Previous Close: $0.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN J MCCABE: Chief Financial Officer, Senior Vice President, Finance
Holdings: 5,930 shares
Current Value: $13,876
Latest Transaction: Apr 05 2017
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN J MCCABE
Sentiment: All, TORC, ILIU, SESN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 06 2019 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Option Exercise | A | 1.27 | 16,400 | 20,828 | 16,400 | |
| Dec 06 2019 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Grant | A | 0.00 | 12,867 | 0 | 12,867 | 0 to 12.9 K |
| Feb 28 2019 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Option Exercise | A | 8.53 | 24,600 | 209,838 | 24,600 | |
| Mar 14 2018 | TORC | resTORbio, Inc. | MCCABE JOHN J | Vice President, Fin ... | Option Exercise | A | 15.45 | 4,603 | 71,116 | 4,603 | |
| Apr 05 2017 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 2.28 | 14,077 | 32,096 | 14,077 | |
| Feb 16 2017 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Sell | S | 2.10 | 1,399 | 2,938 | 5,930 | 7.3 K to 5.9 K (-19.09 %) |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 3.37 | 100,000 | 337,000 | 100,000 |